Alvotech (ALVO) Retained Earnings (2020 - 2026)
Alvotech's (ALVO) quarterly Retained Earnings came in at -$2.5 billion in Q2 2026, down 7.82% on a YoY basis from -$2.7 billion in Q2 2025, and down 2.77% quarter-over-quarter from -$2.4 billion in Q1 2026.
Analysis
Alvotech (ALVO) Retained Earnings (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Retained Earnings for 7 consecutive years, with -$2.5 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings fell 7.82% year-over-year to -$2.5 billion; the trailing twelve-month figure through Jun 2026 stood at -$2.5 billion (down 7.82% YoY), and the FY2025 full-year result was -$2.4 billion, up 1.15% from the prior year.
- Retained Earnings declined to -$2.5 billion in Q2 2026 per ALVO's latest filing, from -$2.4 billion in the prior quarter.
- Across five years, Retained Earnings topped out at -$1.3 billion in Q2 2022 and bottomed at -$2.5 billion in Q2 2026.
- Historically, Retained Earnings has averaged -$2.2 billion across 5 years, with a median of -$2.4 billion in 2024.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 45.03% in 2022, then climbed 2.69% in 2025.
- Over 5 years, Retained Earnings stood at -$1.7 billion in 2022, then sank by 33.36% to -$2.2 billion in 2023, then declined by 10.51% to -$2.4 billion in 2024, then increased by 1.15% to -$2.4 billion in 2025, then decreased by 2.73% to -$2.5 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$2.5 billion, -$2.4 billion, and -$2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 28.26 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 18.56 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 3.76 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 545.58 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | -10.83 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -2.48 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 620.25 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 703.65 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | -227.25 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | -413.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.48 Bn |
| Mar 31, 2026 | -2.41 Bn |
| Dec 31, 2025 | -2.41 Bn |
| Sep 30, 2025 | -2.44 Bn |
| Jun 30, 2025 | -2.30 Bn |
| Mar 31, 2025 | -2.44 Bn |
| Dec 31, 2024 | -2.44 Bn |
| Sep 30, 2024 | -2.37 Bn |
| Jun 30, 2024 | -2.36 Bn |
| Mar 31, 2024 | -2.42 Bn |
| Dec 31, 2023 | -2.21 Bn |
| Jun 30, 2023 | -1.74 Bn |
| Dec 31, 2022 | -1.65 Bn |
| Jun 30, 2022 | -1.33 Bn |
| Dec 31, 2021 | -1.14 Bn |
| Dec 31, 2020 | -1.04 Bn |